Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers

Kunihiko Hiraiwa, Hiroya Takeuchi, Hirotoshi Hasegawa, Yoshiro Saikawa, Koichi Suda, Takashi Ando, Koshi Kumagai, Tomoyuki Irino, Takahisa Yoshikawa, Sachiko Matsuda, Masaki Kitajima, Yuukou Kitagawa

研究成果: Article

128 引用 (Scopus)

抄録

Background: Circulating tumor cells (CTCs) measured by the CellSearch system in metastatic breast cancer have been reported to correlate with shorter overall survival. The purpose of this study was to clarify the clinicopathologic characteristics of CTCs in gastrointestinal cancers. Methods: Pre- and postoperative CTCs from 130 gastrointestinal cancer patients and 41 healthy volunteers were measured by this system. Correlation between CTC counts and clinicopathologic variables was examined. Results: The number of CTCs in metastatic patients (n = 79) was larger than in nonmetastatic patients (n = 35) and in healthy donors (n = 41) (P < 0.001). CTC counts were larger in metastatic gastric cancer (n = 27) than in nonmetastatic gastric cancer (n = 14) (P = 0.016). Two or more CTCs was significantly correlated with advanced tumor stage in all gastrointestinal cancers (P < 0.001) and in gastric cancer (P = 0.032). Two or more CTCs had significant correlation with peritoneal dissemination of gastric or colorectal cancer (P = 0.007) and pleural dissemination of esophageal cancer (P = 0.033). The survival of patients with ≥2 CTCs was shorter than that of patients with <2 CTCs (P = 0.005). The change in CTCs tended to correlate with disease progression and chemotherapeutic effect. Conclusion: This study suggests that measurement of CTCs in gastrointestinal cancer patients could be useful as a tool for judging tumor stage, predicting the presence of peritoneal or pleural dissemination and patients' survival, and monitoring response to cancer therapy.

元の言語English
ページ(範囲)3092-3100
ページ数9
ジャーナルAnnals of Surgical Oncology
15
発行部数11
DOI
出版物ステータスPublished - 2008 11

Fingerprint

Circulating Neoplastic Cells
Gastrointestinal Neoplasms
Stomach Neoplasms
Survival
Cell Count
Neoplasms
Physiologic Monitoring
Esophageal Neoplasms
Disease Progression
Colorectal Neoplasms
Healthy Volunteers

ASJC Scopus subject areas

  • Surgery
  • Oncology

これを引用

Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. / Hiraiwa, Kunihiko; Takeuchi, Hiroya; Hasegawa, Hirotoshi; Saikawa, Yoshiro; Suda, Koichi; Ando, Takashi; Kumagai, Koshi; Irino, Tomoyuki; Yoshikawa, Takahisa; Matsuda, Sachiko; Kitajima, Masaki; Kitagawa, Yuukou.

:: Annals of Surgical Oncology, 巻 15, 番号 11, 11.2008, p. 3092-3100.

研究成果: Article

Hiraiwa, K, Takeuchi, H, Hasegawa, H, Saikawa, Y, Suda, K, Ando, T, Kumagai, K, Irino, T, Yoshikawa, T, Matsuda, S, Kitajima, M & Kitagawa, Y 2008, 'Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers', Annals of Surgical Oncology, 巻. 15, 番号 11, pp. 3092-3100. https://doi.org/10.1245/s10434-008-0122-9
Hiraiwa, Kunihiko ; Takeuchi, Hiroya ; Hasegawa, Hirotoshi ; Saikawa, Yoshiro ; Suda, Koichi ; Ando, Takashi ; Kumagai, Koshi ; Irino, Tomoyuki ; Yoshikawa, Takahisa ; Matsuda, Sachiko ; Kitajima, Masaki ; Kitagawa, Yuukou. / Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. :: Annals of Surgical Oncology. 2008 ; 巻 15, 番号 11. pp. 3092-3100.
@article{068b98b9bb654eb6a8a1a97fcf260bde,
title = "Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers",
abstract = "Background: Circulating tumor cells (CTCs) measured by the CellSearch system in metastatic breast cancer have been reported to correlate with shorter overall survival. The purpose of this study was to clarify the clinicopathologic characteristics of CTCs in gastrointestinal cancers. Methods: Pre- and postoperative CTCs from 130 gastrointestinal cancer patients and 41 healthy volunteers were measured by this system. Correlation between CTC counts and clinicopathologic variables was examined. Results: The number of CTCs in metastatic patients (n = 79) was larger than in nonmetastatic patients (n = 35) and in healthy donors (n = 41) (P < 0.001). CTC counts were larger in metastatic gastric cancer (n = 27) than in nonmetastatic gastric cancer (n = 14) (P = 0.016). Two or more CTCs was significantly correlated with advanced tumor stage in all gastrointestinal cancers (P < 0.001) and in gastric cancer (P = 0.032). Two or more CTCs had significant correlation with peritoneal dissemination of gastric or colorectal cancer (P = 0.007) and pleural dissemination of esophageal cancer (P = 0.033). The survival of patients with ≥2 CTCs was shorter than that of patients with <2 CTCs (P = 0.005). The change in CTCs tended to correlate with disease progression and chemotherapeutic effect. Conclusion: This study suggests that measurement of CTCs in gastrointestinal cancer patients could be useful as a tool for judging tumor stage, predicting the presence of peritoneal or pleural dissemination and patients' survival, and monitoring response to cancer therapy.",
author = "Kunihiko Hiraiwa and Hiroya Takeuchi and Hirotoshi Hasegawa and Yoshiro Saikawa and Koichi Suda and Takashi Ando and Koshi Kumagai and Tomoyuki Irino and Takahisa Yoshikawa and Sachiko Matsuda and Masaki Kitajima and Yuukou Kitagawa",
year = "2008",
month = "11",
doi = "10.1245/s10434-008-0122-9",
language = "English",
volume = "15",
pages = "3092--3100",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers

AU - Hiraiwa, Kunihiko

AU - Takeuchi, Hiroya

AU - Hasegawa, Hirotoshi

AU - Saikawa, Yoshiro

AU - Suda, Koichi

AU - Ando, Takashi

AU - Kumagai, Koshi

AU - Irino, Tomoyuki

AU - Yoshikawa, Takahisa

AU - Matsuda, Sachiko

AU - Kitajima, Masaki

AU - Kitagawa, Yuukou

PY - 2008/11

Y1 - 2008/11

N2 - Background: Circulating tumor cells (CTCs) measured by the CellSearch system in metastatic breast cancer have been reported to correlate with shorter overall survival. The purpose of this study was to clarify the clinicopathologic characteristics of CTCs in gastrointestinal cancers. Methods: Pre- and postoperative CTCs from 130 gastrointestinal cancer patients and 41 healthy volunteers were measured by this system. Correlation between CTC counts and clinicopathologic variables was examined. Results: The number of CTCs in metastatic patients (n = 79) was larger than in nonmetastatic patients (n = 35) and in healthy donors (n = 41) (P < 0.001). CTC counts were larger in metastatic gastric cancer (n = 27) than in nonmetastatic gastric cancer (n = 14) (P = 0.016). Two or more CTCs was significantly correlated with advanced tumor stage in all gastrointestinal cancers (P < 0.001) and in gastric cancer (P = 0.032). Two or more CTCs had significant correlation with peritoneal dissemination of gastric or colorectal cancer (P = 0.007) and pleural dissemination of esophageal cancer (P = 0.033). The survival of patients with ≥2 CTCs was shorter than that of patients with <2 CTCs (P = 0.005). The change in CTCs tended to correlate with disease progression and chemotherapeutic effect. Conclusion: This study suggests that measurement of CTCs in gastrointestinal cancer patients could be useful as a tool for judging tumor stage, predicting the presence of peritoneal or pleural dissemination and patients' survival, and monitoring response to cancer therapy.

AB - Background: Circulating tumor cells (CTCs) measured by the CellSearch system in metastatic breast cancer have been reported to correlate with shorter overall survival. The purpose of this study was to clarify the clinicopathologic characteristics of CTCs in gastrointestinal cancers. Methods: Pre- and postoperative CTCs from 130 gastrointestinal cancer patients and 41 healthy volunteers were measured by this system. Correlation between CTC counts and clinicopathologic variables was examined. Results: The number of CTCs in metastatic patients (n = 79) was larger than in nonmetastatic patients (n = 35) and in healthy donors (n = 41) (P < 0.001). CTC counts were larger in metastatic gastric cancer (n = 27) than in nonmetastatic gastric cancer (n = 14) (P = 0.016). Two or more CTCs was significantly correlated with advanced tumor stage in all gastrointestinal cancers (P < 0.001) and in gastric cancer (P = 0.032). Two or more CTCs had significant correlation with peritoneal dissemination of gastric or colorectal cancer (P = 0.007) and pleural dissemination of esophageal cancer (P = 0.033). The survival of patients with ≥2 CTCs was shorter than that of patients with <2 CTCs (P = 0.005). The change in CTCs tended to correlate with disease progression and chemotherapeutic effect. Conclusion: This study suggests that measurement of CTCs in gastrointestinal cancer patients could be useful as a tool for judging tumor stage, predicting the presence of peritoneal or pleural dissemination and patients' survival, and monitoring response to cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=55149111852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55149111852&partnerID=8YFLogxK

U2 - 10.1245/s10434-008-0122-9

DO - 10.1245/s10434-008-0122-9

M3 - Article

C2 - 18766405

AN - SCOPUS:55149111852

VL - 15

SP - 3092

EP - 3100

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 11

ER -